Lars Anders

3.2k citations

12 papers · 1.5k indexed · 2 hit papers · h-index 7

Impact in

Oncology top 5%
- Cancer-related Molecular Pathways
Molecular Biology top 10%
- Genomics and Chromatin Dynamics
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- RNA Research and Splicing

Papers in ⓘ

Molecular Biology 7
- Protein Degradation and Inhibitors 3
- Genomics and Chromatin Dynamics 3
- Ubiquitin and proteasome pathways 2
Oncology 6
- Cancer-related Molecular Pathways 4

Co-authors: Yoojin Choi (1 shared paper)Richard A. Young (5 shared papers)Piotr Siciński (3 shared papers)Yoon Jong Choi (2 shared papers)Per Hydbring (2 shared papers)Pascal Falter‐Braun (1 shared paper)Marc Vidal (1 shared paper)Nan Rosemary Ke (1 shared paper)
Journals: Cancer Research (3 papers)Molecular and Cellular Biology (1 paper)Science (1 paper)Diabetes (1 paper)Developmental Cell (1 paper)
Partner nations: United States Belgium Germany

In The Last Decade

Lars Anders

12 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element 2014 · 538 citations

Peers

Countries citing papers authored by Lars Anders

Since Specialization

Citations

This map shows the geographic impact of Lars Anders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Anders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Anders more than expected).

Fields of papers citing papers by Lars Anders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Anders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Anders. The network helps show where Lars Anders may publish in the future.

Co-authors

The 25 scholars most cited alongside Lars Anders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Anders Line = papers co-authored together Lars Anders links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element Science ·Marc R. Mansour, Brian J. Abraham, Lars Anders, Alla Berezovskaya, Alejandro Gutiérrez, Adam D. Durbin, Julia Etchin, Lee N. Lawton, Stephen E. Sallan, Lewis B. Silverman, Mignon L. Loh, Stephen P. Hunger, Takaomi Sanda, Richard A. Young, A. Thomas Look Hit paper breakdown →	2014	538
2	A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells Cancer Cell ·Lars Anders, Nan Rosemary Ke, Per Hydbring, Yoon Jong Choi, Hans R. Widlund, Joel M. Chick, Huili Zhai, Marc Vidal, Stephen P. Gygi, Pascal Falter‐Braun, Piotr Siciński Hit paper breakdown →	2011	431
3	Signaling through cyclin D-dependent kinases Oncogene ·Yoojin Choi, Lars Anders	2013	225
4	Genome-wide determination of drug localization Digital Access to Scholarship at Harvard (DASH) (Harvard University) ·Lars Anders, Matthew G. Guenther, Jun Qi, Zi Peng Fan, Jason Marineau, Peter B. Rahl, Jakob Lovén, Alla A. Sigova, William Smith, Tong Ihn Lee, James E. Bradner, Richard A. Young	2014	137
5	Furin-, ADAM 10-, and γ-Secretase-Mediated Cleavage of a Receptor Tyrosine Phosphatase and Regulation of β-Catenin's Transcriptional Activity Molecular and Cellular Biology ·Lars Anders, Philipp Mertins, Sven Lammich, Marta Murgia, Dieter Hartmann, Paul Säftig, Christian Haass, Axel Ullrich	2006	87
6	Cyclin D1 Represses Gluconeogenesis via Inhibition of the Transcriptional Coactivator PGC1α Diabetes ·Kavita Bhalla, Wan-Ju Liu, Keyata N. Thompson, Lars Anders, Srikripa Devarakonda, Ruby Dewi, Stephanie Buckley, Bor‐Jang Hwang, Brian M. Polster, Susan G. Dorsey, Yezhou Sun, Piotr Siciński, Geoffrey D. Girnun	2014	45
7	D-Cyclins Repress Apoptosis in Hematopoietic Cells by Controlling Death Receptor Fas and Its Ligand FasL Developmental Cell ·Yoon Jong Choi, Borja Sáez, Lars Anders, Per Hydbring, Joanna Stefano, Nickolas A. Bacon, Colleen Cook, Ilona Kalaszczyńska, Sabina Signoretti, Richard A. Young, David T. Scadden, Piotr Siciński	2014	23
8	Abstract 5709: PF-07104091, a first-in-class CDK2-selective inhibitor for the treatment of HR+/HER2- breast cancer and CCNE1high ovarian cancer Cancer Research ·Chen Shen, Ming Qiu, Nanni Huser, Bernadette Pascual, Qin Zhang, Todd VanArsdale, Anwar Murtaza, Jonathan Almaden, Bugeun Kim, Lars Anders, Koleen Eisele	2024	6
9	Abstract ND12: Discovery of PF-07220060, a potent and selective CDK4 inhibitor Cancer Research ·Lars Anders, Gary M. Gallego	2024	2
10	354P Synergistic preclinical efficacy through combination of the CDK4 and CDK2 selective inhibitors, PF-07220060 and PF-07104091, respectively, in HR+ HER2- breast cancer Annals of Oncology ·Lars Anders, Todd Van Arsdale, Sudhakar Chintharlapalli, Britton Boras, J. Cianfrogna, Nanni Huser, Belén Pascual, Chen Shen, Min Qiu, Aida Sacaan, Rhys Jones	2024	1
11	Genome-wide localization of small molecules Nature Biotechnology ·Lars Anders, Matthew G. Guenther, Jun Qi, Zi Peng Fan, Jason Marineau, Peter B. Rahl, Jakob Lovén, Alla A. Sigova, William Smith, Tong Ihn Lee, James E. Bradner, Richard A. Young	2013	1
12	Abstract 2007: Transcriptional regulatory program controlled by the oncogenic transcription factor LMO1 in neuroblastoma Cancer Research ·Takaomi Sanda, Koshi Akahanse, Brian J. Abraham, Nina Weichert, Adam D. Durbin, Lars Anders, Shi Hao Tan, Alice Wei Yee Yam, Lee N. Lawton, Richard A. Young, John M. Maris, A. Thomas Look	2016	1

About Lars Anders

Lars Anders is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cell Biology and Cancer Research, having authored 12 papers that have together received 1.5k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (5 papers), Cancer-related Molecular Pathways (4 papers), Protein Degradation and Inhibitors (3 papers), Genomics and Chromatin Dynamics (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Ubiquitin and proteasome pathways (2 papers), Microtubule and mitosis dynamics (2 papers) and Neuroblastoma Research and Treatments (1 paper). The work is most often cited by research in Oncology (497 citations), Molecular Biology (1.1k citations), Cancer Research (223 citations), Hematology (129 citations) and Pulmonary and Respiratory Medicine (306 citations). Lars Anders has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Yoojin Choi, Richard A. Young, Piotr Siciński, Yoon Jong Choi, Per Hydbring, Pascal Falter‐Braun, Marc Vidal, Nan Rosemary Ke, Stephen P. Gygi and Joel M. Chick. Their work appears in journals such as Cancer Research, Molecular and Cellular Biology, Science, Diabetes and Developmental Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact